Outcomes of reoperative surgery in severely obese patients after sleeve gastrectomy: a single-institution experience.


Journal

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
ISSN: 1878-7533
Titre abrégé: Surg Obes Relat Dis
Pays: United States
ID NLM: 101233161

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 04 11 2019
revised: 10 04 2020
accepted: 16 04 2020
pubmed: 9 6 2020
medline: 28 4 2021
entrez: 9 6 2020
Statut: ppublish

Résumé

Despite its popularity, sleeve gastrectomy (SG) is not devoid of postoperative complications and weight regain. Some of these cases warrant conversion to Roux-en-Y gastric bypass or proximal gastrectomy with Roux-en-Y esophagojejunostomy. Complications after conversion are scarcely reported in the literature. Report and review the outcomes of reoperation on severely obese patients with weight regain or complications after SG. Bariatric Surgery Center of Excellence; Community Hospital, United States. We retrospectively reviewed the medical records of patients converted from SG to Roux-en-Y gastric bypass/proximal gastrectomy with Roux-en-Y esophagojejunostomy at our center, from 2004 to 2018. Patients were stratified by reason for conversion. Group A included those converted for complications (leaks, strictures, or gastroesophageal reflux disease) and group B for reported weight regain. Demographic characteristics, postoperative outcomes, and complications were described. From 77 conversions identified, 63.6% (n = 49) underwent primary SG at an outside hospital. We observed predominant female (68.8%; n = 53) and Caucasian (76.6%; n = 59) populations. Conversions for complications were performed in 67.5% (n = 52) and for weight regain in 32.4% (n = 25). The most common conversion indication in group A was chronic leak (29.9%; n = 23), followed by gastroesophageal reflux disease (20.8%; n = 16), and stricture (16.9%; n = 13). Overall, major complications occurred in 16.9% (n = 13) and minor complications in 19.4% (n = 15). In group A, most common major complications were anastomotic leak and organ space surgical site infection (3.9%; n = 2 each); the most common minor complication was nonperforated marginal ulcer (7.7%; n = 4). In group B, the most common major complication was perforated marginal ulcer (8%; n = 2); the most common minor complication was stricture (16%; n = 4). Group B mean preconversion body mass index was 38.4 ± 4.3 and percentage excess body mass index loss was 48 ± 33, 63 ± 45, 59 ± 63, and 73 ± 25 (12, 24, 36, ≥48 mo). Our experience shows that major complications can occur in up to 17% of patients after conversion. Conversion to Roux-en-Y gastric bypass in nonresponders appears to be a safe and effective option for body mass index reduction.

Sections du résumé

BACKGROUND BACKGROUND
Despite its popularity, sleeve gastrectomy (SG) is not devoid of postoperative complications and weight regain. Some of these cases warrant conversion to Roux-en-Y gastric bypass or proximal gastrectomy with Roux-en-Y esophagojejunostomy. Complications after conversion are scarcely reported in the literature.
OBJECTIVES OBJECTIVE
Report and review the outcomes of reoperation on severely obese patients with weight regain or complications after SG.
SETTING METHODS
Bariatric Surgery Center of Excellence; Community Hospital, United States.
METHODS METHODS
We retrospectively reviewed the medical records of patients converted from SG to Roux-en-Y gastric bypass/proximal gastrectomy with Roux-en-Y esophagojejunostomy at our center, from 2004 to 2018. Patients were stratified by reason for conversion. Group A included those converted for complications (leaks, strictures, or gastroesophageal reflux disease) and group B for reported weight regain. Demographic characteristics, postoperative outcomes, and complications were described.
RESULTS RESULTS
From 77 conversions identified, 63.6% (n = 49) underwent primary SG at an outside hospital. We observed predominant female (68.8%; n = 53) and Caucasian (76.6%; n = 59) populations. Conversions for complications were performed in 67.5% (n = 52) and for weight regain in 32.4% (n = 25). The most common conversion indication in group A was chronic leak (29.9%; n = 23), followed by gastroesophageal reflux disease (20.8%; n = 16), and stricture (16.9%; n = 13). Overall, major complications occurred in 16.9% (n = 13) and minor complications in 19.4% (n = 15). In group A, most common major complications were anastomotic leak and organ space surgical site infection (3.9%; n = 2 each); the most common minor complication was nonperforated marginal ulcer (7.7%; n = 4). In group B, the most common major complication was perforated marginal ulcer (8%; n = 2); the most common minor complication was stricture (16%; n = 4). Group B mean preconversion body mass index was 38.4 ± 4.3 and percentage excess body mass index loss was 48 ± 33, 63 ± 45, 59 ± 63, and 73 ± 25 (12, 24, 36, ≥48 mo).
CONCLUSIONS CONCLUSIONS
Our experience shows that major complications can occur in up to 17% of patients after conversion. Conversion to Roux-en-Y gastric bypass in nonresponders appears to be a safe and effective option for body mass index reduction.

Identifiants

pubmed: 32507733
pii: S1550-7289(20)30241-0
doi: 10.1016/j.soard.2020.04.036
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

983-990

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Joel S Frieder (JS)

Department of General Surgery and the Bariatric and Metabolic Institute, Cleveland Clinic, Weston, Florida.

Rene Aleman (R)

Department of General Surgery and the Bariatric and Metabolic Institute, Cleveland Clinic, Weston, Florida.

Camila Ortiz Gomez (CO)

Department of General Surgery and the Bariatric and Metabolic Institute, Cleveland Clinic, Weston, Florida.

Francisco Ferri (F)

Department of General Surgery and the Bariatric and Metabolic Institute, Cleveland Clinic, Weston, Florida.

Luis Felipe Okida (LF)

Department of General Surgery and the Bariatric and Metabolic Institute, Cleveland Clinic, Weston, Florida.

David Romero Funes (DR)

Department of General Surgery and the Bariatric and Metabolic Institute, Cleveland Clinic, Weston, Florida.

Emanuele Lo Menzo (E)

Department of General Surgery and the Bariatric and Metabolic Institute, Cleveland Clinic, Weston, Florida.

Samuel Szomstein (S)

Department of General Surgery and the Bariatric and Metabolic Institute, Cleveland Clinic, Weston, Florida.

Raul J Rosenthal (RJ)

Department of General Surgery and the Bariatric and Metabolic Institute, Cleveland Clinic, Weston, Florida. Electronic address: rosentr@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH